Sci Show: Rapid decay of Anti–SARS-CoV-2 antibodies in people with mild Covid-19 raises concern that immunity may not be long lasting in those with mild illness, who compose the majority of infections, finds new study in NEJM (21 July 2020), with implications for herd immunity and vaccine effectiveness.

Tuesday, July 21, 2020

Rapid decay of Anti–SARS-CoV-2 antibodies in people with mild Covid-19 raises concern that immunity may not be long lasting in those with mild illness, who compose the majority of infections, finds new study in NEJM (21 July 2020), with implications for herd immunity and vaccine effectiveness.

https://ift.tt/32GlN7V via /r/science https://ift.tt/3huq3f3

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)